Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma (PRP) injections successfully treated a woman's steroid-resistant hair loss, causing hair to regrow within a month.

Multiple courses of pulse corticosteroid therapy improve hair growth in alopecia areata patients with minimal side effects.

Low-dose oral minoxidil and finasteride effectively improve hair growth in men with androgenetic alopecia.

Virtual healthcare significantly improves quality of life for men with hair loss if they stick to the treatment.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

HDMHG0401-10 treatment significantly improved hair count and was better than a placebo in reducing hair loss in men with hereditary hair loss, with no major side effects.

The trial aims to test a new treatment for hair loss in young men using stem cell-derived vesicles.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Ayurveda-based care improved quality of life for breast cancer patients without serious side effects.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.

Both fat-derived stem cells and platelet-rich plasma are effective and safe for hair loss, but stem cells give better results with more side effects.

The inhibitor affects androgen metabolism but not ovarian function.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Cross-section trichometry is an accurate method to measure hair loss and growth.

Recent advances in hair loss treatments show significant progress.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Topical eflornithine helps maintain hair reduction after IPL therapy in women with facial hirsutism.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

The treatment is safe and very effective for hair growth in Asian men with minimal side effects.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

A natural extract-based hair growth product was developed and showed promise in preliminary tests.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

The treatment increased hair follicle counts and is potentially effective for male hair loss without serious side effects.

Alopecia areata severity is linked to increased TH1 and TH2 activity.